nRichDX Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 20


  • Latest Deal Type
  • Series A
  • (In Progress)

  • Latest Deal Amount
  • $20M

  • Investors
  • 1

nRichDX General Information


Developer of a medical device designed to provide a patented technology for liquid biopsy applications. The company's device is a differentiated, universal sample preparation system for the multi-billion dollar liquid biopsy and precision medicine markets that solves the problem of inaccurate diagnostic results of liquid biopsy-based molecular diagnostic tests like NGS, PCR, and MicroArray, due to a lack of target material, helping healthcare companies to improve workflow, greatly enhancing test sensitivity and producing consistently reliable test results while increasing revenue and reducing operational costs and complexity.

Contact Information

Formerly Known As
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Corporate Office
  • 15339 Barranca Parkway
  • Irvine, CA 92618
  • United States
+1 (949) 000-0000

nRichDX Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

nRichDX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) 04-Oct-2023 $20M 0000 In Progress Generating Revenue/Not Profitable
6. Later Stage VC 30-Jun-2022 000 0000 Completed Generating Revenue/Not Profitable
5. Later Stage VC 17-Jun-2020 00.000 0000 Completed Generating Revenue
4. Early Stage VC 19-Nov-2019 00.000 000 Completed Generating Revenue
3. Early Stage VC 30-Oct-2017 00.00 00.000 Completed Generating Revenue
2. Early Stage VC 01-May-2016 $2.33M $4.58M Completed Generating Revenue
1. Early Stage VC 16-Jul-2015 $2.25M $2.25M Completed Startup
To view nRichDX’s complete valuation and funding history, request access »

nRichDX Comparisons

HQ Location
Total Raised
Post Valuation
Developer of a medical device designed to provide a patented technology for liquid biopsy applications. The company's de
Diagnostic Equipment
Irvine, CA
20 As of 2024
00000000000 0000


illum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non pro
000000000 00000 (000
Madison, WI
0000 As of 0000


m ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incid
Hilden, Germany
0000 As of 0000
000.00 0000-00-00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

nRichDX Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Promega Formerly PE-Backed Madison, WI 0000 000000000000
Qiagen Formerly VC-backed Hilden, Germany 0000 00000 000000&0
CellSearch Corporate Backed or Acquired Huntingdon Valley, PA 000000&0
Thermo Fisher Scientific Private Equity-Backed Waltham, MA 000000 000.00 000000000 000.00
To view nRichDX’s complete competitors history, request access »

nRichDX Executive Team (10)

Name Title Board Seat Contact Info
William Curtis Co-Founder, Chief Executive Officer & Board Member
David Parker Chief Financial Officer
Nafiseh Jafari Ph.D Chief Science Officer
Jack McGinley Co-Founder & Chairman of the Board of Directors
Robert Coleman Ph.D Founder & Board Member
You’re viewing 5 of 10 executive team members. Get the full list »

nRichDX Board Members (4)

Name Representing Role Since
Jack McGinley nRichDX Co-Founder & Chairman of the Board of Directors 000 0000
Robert Coleman Ph.D nRichDX Founder & Board Member 000 0000
Wayne Wu Self Board Member 000 0000
William Curtis nRichDX Co-Founder, Chief Executive Officer & Board Member 000 0000
To view nRichDX’s complete board members history, request access »

nRichDX Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

nRichDX Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Signatures Capital Venture Capital Minority 000 0000 000000 0
To view nRichDX’s complete investors history, request access »

nRichDX FAQs

  • When was nRichDX founded?

    nRichDX was founded in 2015.

  • Who is the founder of nRichDX?

    William Curtis, Jack McGinley, and Robert Coleman Ph.D are the founders of nRichDX.

  • Who is the CEO of nRichDX?

    William Curtis is the CEO of nRichDX.

  • Where is nRichDX headquartered?

    nRichDX is headquartered in Irvine, CA.

  • What is the size of nRichDX?

    nRichDX has 20 total employees.

  • What industry is nRichDX in?

    nRichDX’s primary industry is Diagnostic Equipment.

  • Is nRichDX a private or public company?

    nRichDX is a Private company.

  • What is nRichDX’s current revenue?

    The current revenue for nRichDX is 00000.

  • How much funding has nRichDX raised over time?

    nRichDX has raised $40M.

  • Who are nRichDX’s investors?

    Signatures Capital has invested in nRichDX.

  • Who are nRichDX’s competitors?

    Promega, Qiagen, CellSearch, and Thermo Fisher Scientific are competitors of nRichDX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »